Sanders Morris Harris’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
EOJOAM
MCP
PCM
YIH
YCM
COPPSERS
MAP
TE
EA
Sanders Morris Harris's CYTK Position: Q2 2026 in Review
Sanders Morris Harris sold out of Cytokinetics (CYTK) in Q2 2026, closing a stake of 21,505 shares — an estimated $1.42M sold.
Sanders Morris Harris first reported a position in CYTK in Q1 2020 and held it in 21 quarters. The position peaked at $2.29M in Q4 2023. 35 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- Sanders Morris Harris reported no remaining Cytokinetics position as of Q2 2026 after selling out during the quarter.
- Sanders Morris Harris sold 21,505 Cytokinetics shares in Q2 2026, an estimated $1.42M.
- Sanders Morris Harris first reported a position in Cytokinetics in Q1 2020 and held it in 21 quarters.
- Sanders Morris Harris's Cytokinetics position peaked at $2.29M in Q4 2023.
- 35 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.